Halozyme Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $92M | 1.8M | 52.02 |
| 2024-12-31 | $79M | 1.6M | 47.81 |
| 2024-09-30 | $94M | 1.6M | 57.24 |
| 2024-06-30 | $67M | 1.3M | 52.36 |
| 2024-03-31 | $55M | 1.4M | 40.68 |
| 2023-12-31 | $47M | 1.3M | 36.95 |
| 2023-09-30 | $40M | 1.0M | 38.20 |
| 2023-06-30 | $40M | 1.1M | 36.07 |
| 2022-12-31 | $64M | 1.1M | 56.90 |
| 2022-06-30 | $38M | 859k | 43.89 |
| 2022-03-31 | $0 | 424k | 0.00 |
| 2021-06-30 | $27M | 603k | 45.38 |
| 2020-12-31 | $22M | 521k | 42.71 |
| 2020-09-30 | $14M | 520k | 26.27 |
| 2020-06-30 | $7.8M | 292k | 26.81 |
| 2020-03-31 | $9.8M | 543k | 18.00 |
| 2019-12-31 | $10M | 587k | 17.73 |
| 2019-09-30 | $8.2M | 528k | 15.50 |
| 2019-03-31 | $4.4M | 274k | 16.10 |
| 2018-12-31 | $6.6M | 452k | 14.63 |
| 2018-09-30 | $11M | 595k | 18.17 |
| 2018-06-30 | $15M | 892k | 16.87 |
| 2018-03-31 | $16M | 834k | 19.59 |
| 2017-12-31 | $12M | 575k | 20.26 |
| 2017-03-31 | $6.6M | 512k | 12.96 |
| 2016-12-31 | $6.1M | 613k | 9.88 |
| 2016-09-30 | $4.3M | 364k | 11.81 |
| 2016-06-30 | $3.1M | 356k | 8.62 |
| 2016-03-31 | $2.8M | 297k | 9.47 |
| 2015-12-31 | $4.3M | 247k | 17.28 |
| 2015-09-30 | $4.2M | 316k | 13.42 |
| 2015-06-30 | $8.9M | 393k | 22.58 |
| 2014-12-31 | $3.0M | 310k | 9.59 |
| 2014-09-30 | $3.3M | 360k | 9.09 |
| 2014-06-30 | $3.0M | 301k | 10.06 |
| 2014-03-31 | $0 | 357k | 0.00 |
| 2013-12-31 | $5.7M | 383k | 14.96 |
| 2013-09-30 | $4.0M | 369k | 10.87 |